oncosynergy.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
Sitemap: https://oncosynergy.com/sitemap.xml Sitemap: https://oncosynergy.com/news-sitemap.xml User-agent: * Disallow: /wp-admin/ Allow:
Meta Tags
Title OncoSynergy – Next generation
Description PATIENT-FOCUSED Clinical Trials Science Overview Scientific Advisory Board Pipeline News About Our Mission Our Team Glioblastoma Connect Fundraisers Contact Us Press ente
Keywords N/A
Server Information
WebSite oncosynergy favicononcosynergy.com
Host IP 50.63.122.1
Location United States
Related Websites
Site Rank
More to Explore
oncosynergy.com Valuation
US$2,343,454
Last updated: 2023-05-02 13:21:55

oncosynergy.com has Semrush global rank of 4,516,540. oncosynergy.com has an estimated worth of US$ 2,343,454, based on its estimated Ads revenue. oncosynergy.com receives approximately 270,399 unique visitors each day. Its web server is located in United States, with IP address 50.63.122.1. According to SiteAdvisor, oncosynergy.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$2,343,454
Daily Ads Revenue US$2,164
Monthly Ads Revenue US$64,896
Yearly Ads Revenue US$778,748
Daily Unique Visitors 18,027
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
oncosynergy.com. A 3600 IP: 50.63.122.1
oncosynergy.com. NS 3600 NS Record: ns64.domaincontrol.com.
oncosynergy.com. NS 3600 NS Record: ns63.domaincontrol.com.
oncosynergy.com. MX 1800 MX Record: 10 mx05-2.sherwebcloud.com.
oncosynergy.com. MX 1800 MX Record: 10 mx05-1.sherwebcloud.com.
oncosynergy.com. TXT 3600 TXT Record: v=verifydomain MS=8110920
HtmlToTextCheckTime:2023-05-02 13:21:55
Clinical Trials Science Overview Scientific Advisory Board Pipeline News About Our Mission Our Team Glioblastoma Connect Fundraisers Contact Us Press enter to begin your search PATIENT-FOCUSED IMMUNOTHERAPIES OncoSynergy is a clinical-stage immuno-oncology company based in Stamford, CT Recurrent Glioblastoma Phase 1 Trial The primary goal of this Phase 1 study is to determine if a new investigational drug, OS2966, when delivered directly to the brain of adult participants with recurrent/progressive high-grade glioma (HGG) is safe and well tolerated. OS2966 is a therapeutic antibody blocking a cell surface receptor governing fundamental biological processes that allow cancer cells to grow, spread and become resistant to cancer treatment. Despite availability of new promising cancer treatments, successful treatment of HGG has been limited by the presence of the brain’s protective blood brain barrier (BBB). The BBB is made up of tightly knit cells that block entry of several substances
HTTP Headers
HTTP/1.1 302 Found
Connection: close
Pragma: no-cache
cache-control: no-cache
Location: /

HTTP/1.1 200 OK
Date: Sun, 24 Oct 2021 23:13:50 GMT
Server: Apache
Link: ; rel="https://api.w.org/", ; rel=shortlink
Content-Type: text/html; charset=UTF-8
oncosynergy.com Whois Information
Domain Name: ONCOSYNERGY.COM
Registry Domain ID: 1634636442_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-01-13T16:54:33Z
Creation Date: 2011-01-12T09:33:53Z
Registry Expiry Date: 2022-01-12T09:33:53Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS63.DOMAINCONTROL.COM
Name Server: NS64.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-13T04:50:21Z <<<

Copyright © 2022 WebZZ.US 0.0228